J&J to Buy Intra-Cellular for About $14 Billion

The video discusses Johnson & Johnson's $14.6 billion acquisition in the biotech sector, focusing on central nervous system disorders. It highlights positive market reactions and compares it to other recent pharmaceutical acquisitions by GSK, Biogen, and Eli Lilly. The video also previews upcoming interviews with CEOs from major companies like Lilly, Alumina, and Teva, touching on their strategic moves and collaborations, including Alumina's cooperation with NVIDIA.

What other companies were mentioned as being involved in recent deals?

What is the significance of the cooperation announced between Alumina and NVIDIA?